However, the incidence rate was higher in the anti-VEGF group (1.06 per 1000 person-years) than in the control group (0.63 per 1000 person-years), though this result did not reach statistical significance (adjusted HR: 2.21, 95% CI: 0.87–5.61).
← all excerpts
Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors - a population-based cohort study.
1
—
—